Global Meningitis Diagnosis and Treatment Market Research Report Forecast to 2023

$4,450$6,250

Clear

Description

Global Meningitis Diagnosis and Treatment Market Research Report: by Type (Viral Meningitis, Bacterial Meningitis, and Others), by Treatment & Diagnosis (Treatment and Diagnosis), by End-user (Hospitals & Clinics, Others), and Region – Forecast till 2023
Market analysis

The Global Meningitis Diagnosis and Treatment Market is relied upon to ascend to a valuation of USD 430.2 million by 2023, ascending at a strong 3.38% CAGR over the conjecture time frame from 2018 to 2023. The global meningitis diagnosis and treatment market is for the most part determined by the developing predominance of meningitis just as the expanding endeavors to battle the infection, including endeavors to diminish the rate of the illness just as endeavors to deal with the ailment better. The developing extent of the human services segment in rising areas is probably going to be a noteworthy driver for the global meningitis diagnosis and treatment market over the conjecture time frame. The growing prevalence of bacterial and viral meningitis is likely to be a major factor for the growth of global meningitis diagnosis and treatment market during the forecast period (2017- 2023).

Market segmentation

The global meningitis diagnosis and treatment market is segmented on the basis of service, end user, disease type, and regional demand. On the basis of its disease type, the global meningitis diagnosis and treatment market is bifurcated into viral meningitis, bacterial meningitis, fungal meningitis, and others. Based on its service, the global meningitis diagnosis and treatment market is categorized into diagnosis and treatment. On the basis of its end user, the global meningitis diagnosis and treatment market is classified into diagnostic centers, hospitals & clinics, and others.

Regional demand

Geographically, the global meningitis diagnosis and treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc., among others are some of the major players in the global meningitis diagnosis and treatment market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Large Patient Population
5.2.2 Increasing Prevalence of Bacterial, Viral, and Fungal Infections
5.2.3 Rising Demand for Point of Care Diagnostic Services for Chronic Diseases
5.3 Restraints
5.3.1 Side-Effects of Antibiotics and Steroids
5.3.2 Lack of Awareness About Meningitis
5.4 Opportunities
5.4.1 Research for the Development of Specific Drugs for the Treatment of Meningitis
5.5 Technology Trends and Assessment
5.5.1 Increasing Focus on Combination Therapies
6 Market Factor Analysis
6.1.1 R&D and Designing
6.1.2 Manufacturing
6.1.3 Distribution & Sales
6.1.4 Post-Sales Monitoring
6.2 Porter’s Five Forces Model
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Buyers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitutes
6.2.5 Intense Rivalry
6.3 Investment Opportunity Analysis
6.3.1 Market size (current and future), growth rate, and profitability
6.3.2 Investment Risks
6.3.3 Market Outlook
6.3.4 Competitors
6.3.5 Projections
6.4 Meningitis Tests (Number of tests for the Europe region)
7 Global Meningitis Diagnosis and Treatment Market, by Type
7.1 Introduction
7.2 Viral Meningitis
7.3 Bacterial Meningitis
7.4 Fungal Meningitis
8 Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis
8.1 Introduction
8.2 Treatment
8.2.1 Antibiotics
8.2.2 Steroids
8.2.3 Antifungal Drugs
8.3 Diagnosis
8.3.1 Spinal Tap (Lumbar Puncture)
8.3.2 Imaging Techniques
8.3.3 Blood Tests
9 Global Meningitis Diagnosis and Treatment Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Diagnostic Centers
10 Global Meningitis Diagnosis and Treatment Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 UK
10.3.1.2 France
10.3.1.3 Germany
10.3.1.4 Spain
10.3.1.5 Italy
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
11.2 Company Market Share Analysis
12 Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Sanofi
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Pfizer Inc.
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 Siemens Healthcare Private Limited
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 GlaxoSmithKline Plc.
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Merck KGaA
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Baxter
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Abbott
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Bio-Rad Laboratories Inc.
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Thermo Fisher Scientific Inc.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Quest Diagnostics Incorporated
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products/Services Offered
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
12.12 Luminex Corporation
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products/Services Offered
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategy
12.13 F. Hoffmann-La Roche Ltd
12.13.1 Company Overview
12.13.2 Financial Overview
12.13.3 Products/Services Offered
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.13.6 Key Strategy
12.14 Cepheid
12.14.1 Company Overview
12.14.2 Financial Overview
12.14.3 Products/Services Offered
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.14.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format